相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mapping proteolytic neo-N termini at the surface of living cells
Amy M. Weeks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Targeting a neoantigen derived from a common TP53 mutation
Emily Han-Chung Hsiue et al.
SCIENCE (2021)
Bispecific antibodies targeting mutant RAS neoantigens
Jacqueline Douglass et al.
SCIENCE IMMUNOLOGY (2021)
Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1
Thomas Kryza et al.
NATURE CHEMICAL BIOLOGY (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Systematic identification of engineered methionines and oxaziridines for efficient, stable, and site-specific antibody bioconjugation
Susanna K. Elledge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer
Anna Moroz et al.
CLINICAL CANCER RESEARCH (2020)
Amyloid structure determination in RELION-3.1
Sjors H. W. Scheres
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2020)
Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma
Thomas Kryza et al.
THERANOSTICS (2020)
Solid Tumors Challenges and New Insights of CAR T Cell Engineering
Safa Tahmasebi et al.
STEM CELL REVIEWS AND REPORTS (2019)
Feasibility and acceptability of combining cognitive behavioural therapy techniques with swallowing therapy in head and neck cancer dysphagia
J. M. Patterson et al.
BMC CANCER (2018)
Structural Basis of Enhanced Crystallizability Induced by a Molecular Chaperone for Antibody Antigen-Binding Fragments
June Ereno-Orbea et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins
Alexander J. Martinko et al.
ELIFE (2018)
Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challenges
N. A. Nixon et al.
CURRENT ONCOLOGY (2018)
CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation
Heather J. Wright et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis
Kuo-Liang Chiu et al.
ONCOTARGET (2017)
Novel small molecule inhibiting CDCP1-PKCδ pathway reduces tumor metastasis and proliferation
Katsuhiko Nakashima et al.
CANCER SCIENCE (2017)
Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance
Y. He et al.
ONCOGENE (2016)
CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer
H. J. Wright et al.
ONCOGENE (2016)
Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling
Ishan Roy et al.
CANCER RESEARCH (2015)
A High Through-put Platform for Recombinant Antibodies to Folded Proteins
Michael Hornsby et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases
C. Leroy et al.
ONCOGENE (2015)
Pericellular proteolysis in cancer
Lisa Sevenich et al.
GENES & DEVELOPMENT (2014)
Oncogenic Ras/ERK Signaling Activates CDCP1 to Promote Tumor Invasion and Metastasis
Takamasa Uekita et al.
MOLECULAR CANCER RESEARCH (2014)
In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling
B. Casar et al.
ONCOGENE (2014)
Stratum basale keratinocyte expression of the cell-surface glycoprotein CDCP1 during epidermogenesis and its role in keratinocyte migration
J. A. McGovern et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Trask Loss Enhances Tumorigenic Growth by Liberating Integrin Signaling and Growth Factor Receptor Cross-Talk in Unanchored Cells
Danislav S. Spassov et al.
CANCER RESEARCH (2013)
Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy
Gwendlyn Kollmorgen et al.
MOLECULAR ONCOLOGY (2013)
Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
Luc R. Desnoyers et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis
Takamasa Uekita et al.
CANCER SCIENCE (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Generation and characterization of antibodies specific for caspase-cleaved neo-epitopes: a novel approach
X. Ai et al.
CELL DEATH & DISEASE (2011)
RAS oncogenes: weaving a tumorigenic web
Yuliya Pylayeva-Gupta et al.
NATURE REVIEWS CANCER (2011)
CUB Domain-Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
Yuri Miyazawa et al.
CANCER RESEARCH (2010)
Proteolysis-induced N-terminal Ectodomain Shedding of the Integral Membrane Glycoprotein CUB Domain-containing Protein 1 (CDCP1) Is Accompanied by Tyrosine Phosphorylation of Its C-terminal Domain and Recruitment of Src and PKCδ
Yaowu He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Inhibition of Tumor Metastasis: Functional Immune Modulation of the CUB Domain Containing Protein 1
Keisuke Fukuchi et al.
MOLECULAR PHARMACEUTICS (2010)
The Transmembrane src Substrate Trask Is an Epithelial Protein that Signals during Anchorage Deprivation
Danislav S. Spassov et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung
Jun-ichiro Ikeda et al.
CANCER SCIENCE (2009)
Phosphorylation of the src Epithelial Substrate Trask Is Tightly Regulated in Normal Epithelia but Widespread in Many Human Epithelial Cancers
Ching Hang Wong et al.
CLINICAL CANCER RESEARCH (2009)
The Cell Surface Glycoprotein CDCP1 in Cancer-Insights, Opportunities, and Challenges
Andreas Wortmann et al.
IUBMB LIFE (2009)
Functional Role of Cell Surface CUB Domain-Containing Protein 1 in Tumor Cell Dissemination
Elena I. Deryugina et al.
MOLECULAR CANCER RESEARCH (2009)
The role of membrane microdomains in transmembrane signaling through the epithelial glycoprotein Gp140/CDCP1
Stacy M. Alvares et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model
Amara C. Siva et al.
CANCER RESEARCH (2008)
Global Sequencing of proteolytic cleavage sites in apoptosis by specific Labeling of protein N termini
Sami Mahrus et al.
CELL (2008)
Adhesion signaling by a novel mitotic substrate of src kinases
AS Bhatt et al.
ONCOGENE (2005)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Erratum: Development of potent monoclonal antibody auristatin conjugates for cancer therapy (vol 21, pg 778, 2003)
SO Doronina et al.
NATURE BIOTECHNOLOGY (2003)
Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen
JD Hooper et al.
ONCOGENE (2003)
Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer
M Scherl-Mostageer et al.
ONCOGENE (2001)
Remarkable roles of proteolysis on and beyond the cell surface
CP Blobel
CURRENT OPINION IN CELL BIOLOGY (2000)
Peptide exosite inhibitors of factor VIIa as anticoagulants
MS Dennis et al.
NATURE (2000)
分享论文
